A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Purpose
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Condition
- Atopic Dermatitis
Eligibility
- Eligible Ages
- Between 12 Years and 100 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Completion of an end of treatment duration visit (Week 24 or Week 52 visit for adult or adolescent studies, respectively) in a rocatinlimab parent study (ROCKET-IGNITE, ROCKET-HORIZON, ROCKET-SHUTTLE, ROCKET-ASTRO, ROCKET-ORBIT, OR ROCKET-VOYAGER) within the past 28 days. - Participants from the parent study ROCKET-ORBIT must achieve an improvement in EASI score at week 52 of at least 60% compared to parent study baseline (EASI 60).
Exclusion Criteria
- Permanent investigational product discontinuation due to safety-related reasons, protocol-defined stopping rules or conditions/reasons unrelated to efficacy during the rocatinlimab parent study (ROCKET-IGNITE, ROCKET-HORIZON, ROCKET-SHUTTLE, ROCKET-ASTRO, ROCKET-ORBIT, OR ROCKET-VOYAGER), or at the time of Screening or Day 1.
Study Design
- Phase
- Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Investigator)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental ARM A: Dose 1 to Dose 1 |
Participants from parent Rocatinlimab studies ROCKET-Ignite, ROCKET-Horizon, ROCKET-SHUTTLE, or ROCKET-ASTRO who received Dose 1 will be randomized or assigned to receive Dose 1 Every 4 Weeks (Q4W) or Every 8 Weeks (Q8W). Participants from parent Rocatinlimab study ROCKET-VOYAGER who received Dose 1 will be assigned to receive Dose 1 Q4W. |
|
Experimental ARM B: Dose 2 to Dose 2 |
Participants from parent Rocatinlimab studies ROCKET-Ignite, ROCKET-SHUTTLE, or ROCKET-ASTRO who received Dose 2 will be randomized or assigned to receive Dose 2 Q4W or Q8W. |
|
Placebo Comparator ARM C: Dose 1 or Dose 2 to Placebo |
Participants from parent Rocatinlimab studies ROCKET-Ignite or ROCKET-Horizon who received Dose 1 will be randomized to receive placebo Q4W. Participants from parent Rocatinlimab study ROCKET-Ignite who received Dose 2 will be randomized to receive placebo Q4W. |
|
Placebo Comparator ARM D: Placebo to Placebo |
Participants from parent Rocatinlimab studies ROCKET- Ignite, ROCKET-Horizon, ROCKET-SHUTTLE, ROCKET-ASTRO, or ROCKET-VOYAGER who received placebo will be randomized or assigned to receive placebo Q4W. |
|
Experimental ARM E: Dose 1, Dose 2, Placebo, or Open-label (OL) to OL Dose 1 |
Participants from parent Rocatinlimab studies ROCKET- Ignite, ROCKET-Horizon, ROCKET- SHUTTLE, ROCKET-ASTRO, or ROCKET-VOYAGER who received Dose 1, Dose 2, or placebo will be assigned to receive OL Rocatinlimab Dose 1 Q4W. Participants who received OL in parent Rocatinlimab study ROCKET- ASTRO will continue to receive OL Rocatinlimab Dose 1 Q4W. All participants from parent Rocatinlimab study ROCKET-Orbit will be assigned to receive OL Rocatinlimab Dose 1 Q4W. |
|
Recruiting Locations
Birmingham, Alabama 35244
Phoenix, Arizona 85006
Phoenix, Arizona 85032
Scottsdale, Arizona 85255
Scottsdale, Arizona 85260
Bryant, Arkansas 72022
Hot Springs, Arkansas 71913
North Little Rock, Arkansas 72117
Bakersfield, California 93301
Canoga Park, California 91303
Dublin, California 94568
Encinitas, California 92024
Fountain Valley, California 92708
Lancaster, California 93534
Long Beach, California 90805
Los Angeles, California 90024
Los Angeles, California 90045
Los Angeles, California 90056
Northridge, California 91325
Pasadena, California 91105
Sacramento, California 95815
Sacramento, California 95816
Sacramento, California 95823
San Diego, California 92120
San Francisco, California 94118
San Francisco, California 94118
Santa Monica, California 90404
Tustin, California 92780
Centennial, Colorado 80112
Boca Raton, Florida 33486
Cape Coral, Florida 33991
Coral Gables, Florida 33134
Coral Springs, Florida 33071
Doral, Florida 33122
Doral, Florida 33172
Hialeah, Florida 33012
Homestead, Florida 33033
Miami Gardens, Florida 33014
Miami Lakes, Florida 33014
Miami, Florida 33155
Miami, Florida 33155
Miami, Florida 33176
Palmetto Bay, Florida 33157
Tampa, Florida 33615
Alpharetta, Georgia 30022
Fayetteville, Georgia 30214
Sandy Springs, Georgia 30328
Boise, Idaho 83706
Chicago, Illinois 60602
Normal, Illinois 61761
Skokie, Illinois 60077
West Dundee, Illinois 60118
Clarksville, Indiana 47129
Indianapolis, Indiana 46250
New Albany, Indiana 47150
Plainfield, Indiana 46168
West Lafayette, Indiana 47906
Leawood, Kansas 66211
Louisville, Kentucky 40241
Murray, Kentucky 42071
Chevy Chase, Maryland 20815
Chevy Chase, Maryland 20815
Towson, Maryland 21204
Brighton, Massachusetts 02135
Ann Arbor, Michigan 48109
Detroit, Michigan 48202
Flint, Michigan 48532
Troy, Michigan 48084
Troy, Michigan 48084
Lee's Summit, Missouri 64064
Saint Louis, Missouri 63110
Lincoln, Nebraska 68505
Omaha, Nebraska 68144
Las Vegas, Nevada 89106
Las Vegas, Nevada 89109
North Las Vegas, Nevada 89030
Reno, Nevada 89509
Albuquerque, New Mexico 87102
Brooklyn, New York 11211
New York, New York 10029
New York, New York 10075
New York, New York 10128
Charlotte, North Carolina 28211
Wilmington, North Carolina 28405
Wilmington, North Carolina 28411
Winston-Salem, North Carolina 27103
Bexley, Ohio 43209
Cincinnati, Ohio 45236
Gahanna, Ohio 43230
Mayfield Heights, Ohio 44124
Springfield, Ohio 45505
Tulsa, Oklahoma 74132
Tulsa, Oklahoma 74137
Medford, Oregon 97504
Portland, Oregon 97201
Portland, Oregon 97210
Camp Hill, Pennsylvania 17011
Philadelphia, Pennsylvania 19103
Pittsburgh, Pennsylvania 15213
Charleston, South Carolina 29425
Rapid City, South Dakota 57702
Hermitage, Tennessee 37076
Austin, Texas 78759
Bellaire, Texas 77401
Cedar Park, Texas 78613
Corpus Christi, Texas 78411
Dallas, Texas 75225
Dallas, Texas 75230
Dallas, Texas 75230
Houston, Texas 77004
Houston, Texas 77030
Kerrville, Texas 78028
Mesquite, Texas 75149
Plano, Texas 75025
San Antonio, Texas 78218
Southlake, Texas 76092
The Woodlands, Texas 77380
Murray, Utah 84107
Forest, Virginia 24551
Norfolk, Virginia 23502
Norfolk, Virginia 23507
Spokane, Washington 99202
More Details
- NCT ID
- NCT05882877
- Status
- Recruiting
- Sponsor
- Amgen